TRINALIN REPETABS 1 MG — DIN 00517895
AZATADINE MALEATE : 1 MG PSEUDOEPHEDRINE SULFATE : 120 MG · SCHERING-PLOUGH CANADA INC · TABLET (EXTENDED-RELEASE) · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is TRINALIN REPETABS?
TRINALIN REPETABS 1 MG contains AZATADINE MALEATE : 1 MG PSEUDOEPHEDRINE SULFATE : 120 MG. It is listed in the Health Canada Drug Product Database under DIN 00517895, held by SCHERING-PLOUGH CANADA INC, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Aug-2007. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Pseudoephedrine, Combinations in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
14 holders have a Canadian DIN containing Pseudoephedrine, Combinations, across 30 DINs, of which 5 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAYER INC | 4 | 3 | AERIUS DUAL ACTION 24 HOUR, AERIUS SINUS + ALLERGY, CLARITIN ALLERGY + SINUS, CLARITIN ALLERGY + SINUS EXTRA STRENGTH | Sourceable in Canada |
| MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | 4 | 1 | ACTIFED TABLETS, BENYLIN D-AH FOR CHILDREN, CHILDREN'S BENADRYL-D ALLERGY & SINUS, REACTINE COMPLETE | Sourceable in Canada |
| SANOFI CONSUMER HEALTH INC | 1 | 1 | ALLEGRA-D | Sourceable in Canada |
| SCHERING-PLOUGH CANADA INC | 7 | 0 | CHLOR-TRIPOLON DECON EXT STR REPETABS 12, CHLOR-TRIPOLON ND SRT, DRIXORAL DAY/NIGHT - SRT/TABS, DRIXORAL SYRUP, DRIXTAB TAB, +2 more | No marketed DIN |
| GLAXO WELLCOME INC. | 2 | 0 | ACTIFED SYRUP, ACTIFED TABLETS | No marketed DIN |
| LABORATOIRES TRIANON INC. | 2 | 0 | VASOFRINIC, VASOFRINIC SIROP | No marketed DIN |
| NOVARTIS CONSUMER HEALTH CANADA INC. | 2 | 0 | TRIAMINIC COLD AND ALLERGY, TRIAMINIC SOFTCHEWS COLD AND ALLERGY | No marketed DIN |
| SCHERING-PLOUGH HEALTHCARE PRODUCTS CANADA, A DIVISION OF SCHERING CANADA INC. | 2 | 0 | CORICIDIN 'D' NASAL AND SINUS CONGESTION, CORICIDIN D NASAL AND SINUS CONGESTION TABLETS | No marketed DIN |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | 1 | 0 | CONTAC EXTEND-C SUSTAINED RELEASE CAPSULES | No marketed DIN |
| ICN CANADA LTD. | 1 | 0 | TRIPROFED TAB | No marketed DIN |
| KV PHARMACEUTICAL COMPANY | 1 | 0 | ONCE-A-DAY BENYLIN COLD CAP | No marketed DIN |
| VANC PHARMACEUTICALS INC | 1 | 0 | COLDIFED SYRUP | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 1 MG |
|---|---|
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Pseudoephedrine, Combinations |
|---|---|
| ATC code | R01BA52 |
| AHFS class | 04:04.92 ; 12:12.12 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00517895 |
|---|---|
| DIN (unpadded, as printed on some documents) | 517895 |
| Brand name | TRINALIN REPETABS |
| Generic / active ingredient | AZATADINE MALEATE : 1 MG PSEUDOEPHEDRINE SULFATE : 120 MG |
| Market authorization holder | SCHERING-PLOUGH CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | R01BA52 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R01BA |
| Current status | CANCELLED POST MARKET |
| Status date | 03-Aug-2007 |
| Original market date | 1983-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
5 of 30 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AERIUS SINUS + ALLERGY | 120 MG | TABLET (EXTENDED-RELEASE) | BAYER INC | MARKETED | 02309300 |
| ALLEGRA-D | 60 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | SANOFI CONSUMER HEALTH INC | MARKETED | 02239853 |
| CLARITIN ALLERGY + SINUS | 5 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | BAYER INC | MARKETED | 01945157 |
| CLARITIN ALLERGY + SINUS EXTRA STRENGTH | 10 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | BAYER INC | MARKETED | 02260557 |
| REACTINE COMPLETE | 120 MG | TABLET (EXTENDED-RELEASE) | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02246162 |
| ACTIFED SYRUP | 1.25 MG / 5 ML | LIQUID | GLAXO WELLCOME INC. | CANCELLED POST MARKET | 00068497 |
| ACTIFED TABLETS | 2.5 MG | TABLET | GLAXO WELLCOME INC. | CANCELLED POST MARKET | 00068500 |
| ACTIFED TABLETS | 60 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | 02238302 |
| AERIUS DUAL ACTION 24 HOUR | 240 MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | BAYER INC | CANCELLED PRE MARKET | 02377195 |
| BENADRYL DECONGESTANT TABLETS | 25 MG | TABLET | WARNER-LAMBERT CANADA INC. | CANCELLED POST MARKET | 02019728 |
2 · Same class — other molecules in ATC R01BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Pseudoephedrine, Combinations | ACTIFED SYRUP · ACTIFED TABLETS · AERIUS DUAL ACTION 24 HOUR · AERIUS SINUS + ALLERGY · +25 more | 30 | 5 | Yes |
| Pseudoephedrine | BALMINIL DECONGESTIONNANT SIROP 30MG/5ML · BENYLIN D FOR INFANTS · CONGEST AID TAB 30MG · CONGEST-EZE TAB 60MG · +26 more | 32 | 0 | Not in Canada |
| Phenylpropanolamine, Combinations | BRONCHODEX D CAP · CHLOR TRIPOLON DECONGEST SYR · COLD & ALLERGY RELIEF - LIQ · COLD DECONGESTANT LONG ACTING CAP · +24 more | 28 | 0 | Not in Canada |
| Phenylephrine, Combinations | ACTIFED PE · CHILDREN'S BENADRYL-D SYRUP · COLD & STUFFY NOSE · COLD LIQUID · +19 more | 24 | 0 | Not in Canada |
| Phenylephrine | BENYLIN COLD STRIPS · BENYLIN D FOR INFANTS · HELP I HAVE A STUFFY NOSE · HELP I HAVE THE SNIFFLES · +9 more | 13 | 0 | Not in Canada |
| Sympathomimetics | EPHEDRINE HCL · EPHEDRINE HCL 8 MG · T-DRENE 1 | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.